Interestingly, studies in stroke and PD models showed that BBB disruption leads to enhanced neuroinflammation and accumulation of toxic forms of α-synuclein, which in turn could promote the progression of neuronal loss by impacting on diverse components of the BBB [(73, 105); Figure 1]. This evidence concerns the gene SNCA and Parkinson disease.